90 studies found for:    interstitial lung disease AND children
Show Display Options
Rank Status Study
21 Completed The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms
Condition: HIV Infections
Intervention: Drug: Zidovudine
22 Unknown  Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications
Conditions: Lung Neoplasm;   Lung Diseases, Interstitial;   Respiratory Tract Infections;   Pleural Effusions
Intervention: Procedure: Respiratory endoscopy
23 Terminated DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)
Conditions: Pneumonia, Interstitial Plasma Cell;   Pneumocystis Carinii Pneumonia;   Pneumonia, Pneumocystis Carinii;   HIV Infections
Interventions: Drug: Pafuramidine maleate (DB289);   Drug: Trimethoprim-Sulfamethoxazole (TMP-SMX)
24 Recruiting A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
Condition: Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Intervention: Drug: Prograf
25 Unknown  Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
Conditions: Interstitial Pneumonitis;   Polymyositis;   Dermatomyositis
Intervention: Drug: Tacrolimus
26 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Anesthesia;   Pain;   Reflux;   Nausea;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure)
Intervention: Drug: Ampicillin
27 Completed Herpesvirus in Idiopathic Pulmonary Fibrosis
Conditions: Lung Diseases;   Herpesvirus Infections
Intervention:
28 Completed Specialized Center of Research in Occupational and Immunologic Lung Disease
Conditions: Lung Diseases, Obstructive;   Asbestosis;   Silicosis;   Pneumoconiosis;   Chronic Obstructive Pulmonary Disease
Intervention:
29 Recruiting Pediatric Vasculitis Initiative
Conditions: Wegeners Granulomatosis (Granulomatosis With Polyangiitis);   Microscopic Polyangiitis;   Churg Strauss Syndrome (Eosinophilic Granulomatosis With Polyangiitis);   Polyarteritis Nodosa;   Takayasu Arteritis;   Primary CNS Vasculitis;   Unclassified Vasculitis
Intervention:
30 Terminated An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Fibrosis;   Lung Disease
Intervention: Drug: Interferon gamma-1b
31 Completed Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography
Conditions: Asthma;   Hypersensitivity;   Lung Diseases;   Wegener's Granulomatosis
Intervention:
32 Recruiting HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia;   Acute Lymphocytic Leukemia;   Myelodysplasia;   Chronic Myeloid Leukemia;   Histiocytosis
Interventions: Drug: Chemotherapy and antibodies;   Device: Miltenyi Biotec CliniMACS;   Procedure: Allogeneic stem cell transplantation
33 Active, not recruiting Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide
Conditions: Surfactant Dysfunction;   Bronchopulmonary Dysplasia
Intervention: Drug: Infasurf (ONY Inc.)
34 Not yet recruiting LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Interventions: Drug: Prednisone;   Drug: Vinblastine;   Drug: mercaptopurine;   Drug: INDOMETHACIN;   Drug: Methotrexate;   Drug: Cytosine Arabinoside;   Drug: 2-chlorodeoxyadenosine;   Procedure: hematopoietic stem cell transplantation (RIC-HSCT);   Biological: Intravenous immunoglobulin
35 Recruiting CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
Conditions: Leukemia;   Lymphoma;   Bone Marrow Failure;   Immunodeficiencies;   Histiocytosis
Interventions: Drug: Full Intensity with TBI;   Drug: Full Intensity;   Drug: Reduced Intensity;   Drug: Reduced Intensity (Fanconi)
36 Unknown  Surfactant Administration During Spontaneous Breathing
Conditions: Pneumothorax;   Pulmonary Interstitial Emphysema;   Bronchopulmonary Dysplasia
Interventions: Procedure: Take care;   Procedure: InSurE
37 Unknown  The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study
Condition: Respiratory Distress Syndrome, Newborn
Intervention: Other: Heliox gas
38 Recruiting Nandrolone Decanoate in the Treatment of Telomeropathies
Conditions: Aplastic Anemia;   Bone Marrow Failure Syndromes;   Idiopathic Pulmonary Fibrosis;   Telomere Shortening
Intervention: Drug: Nandrolone Decanoate
39 Not yet recruiting Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
Conditions: Granulomatosis With Polyangiitis (Wegener's);   Granulomatosis With Polyangiitis;   Wegener's Granulomatosis;   ANCA-Associated Vasculitis
Interventions: Drug: Abatacept;   Drug: placebo
40 Recruiting CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Conditions: Bone Marrow Failure Syndrome;   Severe Aplastic Anemia;   Severe Congenital Neutropenia;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Schwachman Diamond Syndrome;   Primary Immunodeficiency Syndromes;   Acquired Immunodeficiency Syndromes;   Histiocytic Syndrome;   Familial Hemophagocytic Lymphocytosis;   Lymphohistiocytosis;   Macrophage Activation Syndrome;   Langerhans Cell Histiocytosis (LCH);   Hemoglobinopathies;   Sickle Cell Disease;   Sickle Cell-beta-thalassemia
Intervention: Biological: CliniMacs (PLUS) Reagent System

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years